146 related articles for article (PubMed ID: 19416653)
1. Effects of docosahexaenoic acid on in vitro amyloid beta peptide 25-35 fibrillation.
Hashimoto M; Shahdat HM; Katakura M; Tanabe Y; Gamoh S; Miwa K; Shimada T; Shido O
Biochim Biophys Acta; 2009 Apr; 1791(4):289-96. PubMed ID: 19416653
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells.
Hossain S; Hashimoto M; Katakura M; Miwa K; Shimada T; Shido O
J Neurochem; 2009 Oct; 111(2):568-79. PubMed ID: 19686246
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
[TBL] [Abstract][Full Text] [Related]
4. Effect of Varying Concentrations of Docosahexaenoic Acid on Amyloid Beta (1⁻42) Aggregation: An Atomic Force Microscopy Study.
Lee BY; Attwood SJ; Turnbull S; Leonenko Z
Molecules; 2018 Nov; 23(12):. PubMed ID: 30486385
[TBL] [Abstract][Full Text] [Related]
5. In vitro antiaggregation and deaggregation potential of Rhizophora mucronata and its bioactive compound (+)- catechin against Alzheimer's beta amyloid peptide (25-35).
Suganthy N; Sheeja Malar D; Pandima Devi K
Neurol Res; 2016 Dec; 38(12):1041-1051. PubMed ID: 27766923
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid withstands the Aβ(25-35)-induced neurotoxicity in SH-SY5Y cells.
Hashimoto M; Katakura M; Hossain S; Rahman A; Shimada T; Shido O
J Nutr Biochem; 2011 Jan; 22(1):22-9. PubMed ID: 20226652
[TBL] [Abstract][Full Text] [Related]
7. Steady-state and time-resolved Thioflavin-T fluorescence can report on morphological differences in amyloid fibrils formed by Aβ(1-40) and Aβ(1-42).
Lindberg DJ; Wranne MS; Gilbert Gatty M; Westerlund F; Esbjörner EK
Biochem Biophys Res Commun; 2015 Mar; 458(2):418-23. PubMed ID: 25660454
[TBL] [Abstract][Full Text] [Related]
8. Curcuminoid binds to amyloid-β1-42 oligomer and fibril.
Yanagisawa D; Taguchi H; Yamamoto A; Shirai N; Hirao K; Tooyama I
J Alzheimers Dis; 2011; 24 Suppl 2():33-42. PubMed ID: 21335654
[TBL] [Abstract][Full Text] [Related]
9. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain.
Castillo GM; Lukito W; Peskind E; Raskind M; Kirschner DA; Yee AG; Snow AD
J Neurosci Res; 2000 Nov; 62(3):451-62. PubMed ID: 11054814
[TBL] [Abstract][Full Text] [Related]
10. Critical role of interfaces and agitation on the nucleation of Abeta amyloid fibrils at low concentrations of Abeta monomers.
Morinaga A; Hasegawa K; Nomura R; Ookoshi T; Ozawa D; Goto Y; Yamada M; Naiki H
Biochim Biophys Acta; 2010 Apr; 1804(4):986-95. PubMed ID: 20100601
[TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic acid stabilizes soluble amyloid-beta protofibrils and sustains amyloid-beta-induced neurotoxicity in vitro.
Johansson AS; Garlind A; Berglind-Dehlin F; Karlsson G; Edwards K; Gellerfors P; Ekholm-Pettersson F; Palmblad J; Lannfelt L
FEBS J; 2007 Feb; 274(4):990-1000. PubMed ID: 17227385
[TBL] [Abstract][Full Text] [Related]
12. Interfacial force-driven pattern formation during drying of Aβ (25-35) fibrils.
Sett A; Bag S; Dasgupta S; DasGupta S
Int J Biol Macromol; 2015 Aug; 79():344-52. PubMed ID: 25964177
[TBL] [Abstract][Full Text] [Related]
13. Charged surfactants induce a non-fibrillar aggregation pathway of amyloid-beta peptide.
Loureiro JA; Rocha S; Pereira Mdo C
J Pept Sci; 2013 Sep; 19(9):581-7. PubMed ID: 23922329
[TBL] [Abstract][Full Text] [Related]
14. Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Yoshiike Y; Takashima A; Yamada M; Naiki H
J Neurochem; 2002 May; 81(3):434-40. PubMed ID: 12065652
[TBL] [Abstract][Full Text] [Related]
15. The effect of tachykinin neuropeptides on amyloid β aggregation.
Flashner E; Raviv U; Friedler A
Biochem Biophys Res Commun; 2011 Apr; 407(1):13-7. PubMed ID: 21352807
[TBL] [Abstract][Full Text] [Related]
16. A beta-amino acid modified heptapeptide containing a designed recognition element disrupts fibrillization of the amyloid beta-peptide.
Castelletto V; Hamley IW; Lim T; De Tullio MB; Castaño EM
J Pept Sci; 2010 Sep; 16(9):443-50. PubMed ID: 20648477
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the behaviour of β-amyloid peptide variants during oligomerization and fibrillation.
Shi JM; Zhang L; Liu EQ
J Pept Sci; 2017 Nov; 23(11):810-817. PubMed ID: 28795459
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
Singh PK; Maji SK
Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
[TBL] [Abstract][Full Text] [Related]
20. Biophysical comparison of soluble amyloid-β(1-42) protofibrils, oligomers, and protofilaments.
Nichols MR; Colvin BA; Hood EA; Paranjape GS; Osborn DC; Terrill-Usery SE
Biochemistry; 2015 Apr; 54(13):2193-204. PubMed ID: 25756466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
